Insight Molecular Diagnostics Inc. — Director's Dealing 2016

Oct 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OncoCyte Corp (OCX)
CIK: 0001642380
Period of Report: 2016-10-17

Reporting Person: BAILEY DON M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-17	Warrant to Purchase Common Stock	$3.25	A	230769	Acquired		Common Stock (230769)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	247001	Direct

Footnotes

F1: The shares are held by Mr. Bailey and his wife as co-trustees of a revocable trust, and in such capacity Mr. Bailey and his wife have shared voting and dispositive power over the shares.

F2: These warrants became exercisable on October 17, 2016, the date shareholders approved the issuance of OncoCyte common stock upon exercise of the warrants, and may be exercised for five years from the date they became exercisable.